Hypoxia-inducible factors (HIFs) belong to a family of transcription factors (TF) responsive to a low O 2 availability, which is often a characteristic feature of solid tumors. The alpha subunit of the HIF heterodimer is O 2 -sensitive, and once stabilized in hypoxia, it functions as a master regulator of various genes involved in hypoxia pathway. Changes in the HIF1A (hypoxia inducible factor 1, alpha subunit) nucleotide sequence or expression has been shown to be associated with the development of several diseases. Because of increasing research interest in HIF1A gene a review of association studies was needed. We here reviewed published data on single nucleotide polymorphisms (SNPs) in HIF1A in various diseases; in total, 34 SNPs were tested for an association with 49 phenotypes, and the results were visualized using the Cytoscape software. Among all collected polymorphisms 16 SNPs showed significant associations with 40 different phenotypes, including six SNPs associated with 14 cancer types. Missense SNPs (rs11549465 and rs11549467) within the oxygen-dependent degradation domain were most frequently studied. The study provides a comprehensive tool for researchers working in this area and may contribute to more accurate disease diagnosis and identification of therapeutic targets.
complex (pVHL) for proteasomal degradation. 1, 6 The pVHL can target cell function, tumor-associated macrophages), and also as part of a systemic response to hypoxia reviewed in Ref. 1 . Besides regulating expression of protein-coding genes, it has been shown that HIF1A also regulates noncoding RNA genes (ncRNA) including microRNAs (miRNAs) 14 and transcribed-ultraconserved regions (T-UCRs) . 15 Although HIF1A gene has been a topic of several studies it is not yet included in the Diseasome map, which visualizes known interactions between genes and diseases. 16 The aim of the present study was to review published reports of associations between HIF1A gene polymorphisms and diseases or phenotypic traits in human and to graphically visualize associations as the gene-disease network.
A literature review of HIF1A polymorphisms, associated diseases, and phenotypes was performed using PubMed (http://www.ncbi.nlm. 
| EXTRACTION OF LITERAT U RE DAT A A N D ED I T I NG A C C O R DI N G TO TH E G EN O M I C D AT AB A S ES
The workflow of the study and main results are presented in Figure 1 .
Polymorphisms' names were edited according the latest genomic browser releases. Usually, articles had polymorphisms defined with rs Figure 2A ).
The studied HIF1A SNPs are located within various genomic regions: 5'-flanking, exons, introns, 3'-UTR, and 3'-flanking (Supporting Information Figure 3 ). An integrated review revealed that among 34 SNPs, 10
showed variable associations (i.e., either present or absent; Table 1 ), six were always positively associated with the tested phenotypes, and 18
showed no association with the tested phenotypes (Table 2, Figure 2B ).
Among all SNPs, missense polymorphisms within the ODD domain (rs11549465 and rs11549467) were most frequently studied and for which variable nomenclature was used in publications. Moreover, several studies that tested associations of these two SNPs with phenotypes showed conflicting results for the same cancer type. For example, opposing results were reported for rs11549465 in prostate cancer susceptibility studies; with association 24, [51] [52] [53] [54] and no association. 113 Increased expression of HIF1A also often associates with poor clinical prognosis of many cancer types. 113 
| H I F 1 A A N D AS S O C I A T I O N W I T H O T H E R PHENOTY P ES AND DISE A SES
Genetic variability of HIF1A was also found to be associated with cardiovascular system diseases like: ischemic heart disease, coronary artery disease (CAD) with stable exertional angina, premature coronary artery disease, pre-eclampsia, acute myocardial infarction, and frequent intra- ) and lung carcinoma (NSCLC) 45, 83, 85 · CRC risk, progression and metastasis 106, 107 · prostate cancer 52, 53, 77 · ovarian, cervical and endometrial cancers 21, 79 · renal cell carcinoma 86, 87 · bladder cancer , and chronic obstructive pulmonary disease (rs11549465 60, 84 ). Moreover, HIF1A SNPs were shown to be involved in metabolic disorders such as: diabetic nephropathy (rs11549465 120 ), which is a result of longstanding type 1 diabetes mellitus (T1DM) (rs11549465 69 ) and type 2 diabetes mellitus (T2DM) (rs11549465, 19, 69 rs12434438, 19 and rs1319462 19 ).
| M O S T F R E Q U E N T L Y S T U D I E D M I S S E NSE SN P S WI T H I N OD D D O M AI N
The review of genotype-phenotype studies revealed that HIF1A association studies were most often focused on two missense SNPs located within the ODD domain: rs11549465 (p.Pro582Ser; C1772T), and showed that the substitution p.Pro582Ser in vitro does not prevent VHL binding to a fragment of HIF1A after hydroxylation at p.Pro564. In the present study we have also collected published negative associations between polymorphisms and phenotypes, since they could be tested also in other populations or in higher number of subjects of the same populations to re-evaluate significance.
As in most association studies, also HIF1A association studies focused on missense SNPs and much less attention was given to syn- We can expect more such studies exploring HIF1A SNPs in clinical trials especially in terms of predicting their effect on favorable or unfavorable therapy outcomes in several other cancers mentioned also in our study. Apart from such pharmacogenetics clinical trials, we can anticipate also gene therapy trials to correct the most damaging germ line mutations in HIF1A as was recently shown for editing the sickle cell anemia mutation by the CRISPR/Cas9 approach. 123 
| C O NC LU S I O N S
Hypoxia is a characteristic feature for many pathological settings;
hence, a stable HIF1A protein is critical for cells to adapt, thrive and survive in a hypoxic environment. The present HIF1A genotype- 
